Short interest in Cartesian Therapeutics Inc (NASDAQ:RNAC) increased during the last reporting period, rising from 1.80M to 2.01M. This put 12.57% of the company's publicly available shares short.

Short interest for Cartesian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cartesian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 162.69K shares traded per day, it would take 12.33 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.